TendoNova Corporation’s mission is to enhance clinical outcomes for patients with chronic tendon pain by delivering cutting edge microinvasive technology that is customizable to individual patient needs without overwhelming expense.
“Investments like TendoNova are a crucial part of the NFLPA’s mission to improve the health, safety and well-being of players both on and off the field. TendoNova’s Ocelot Nano will help players from all levels of the game overcome nagging injuries so they don’t become lifelong problems.”